"10.1371_journal.pone.0016800","plos one","2011-02-23T00:00:00Z","Gabriel Kigen; Sylvester Kimaiyo; Winstone Nyandiko; Brian Faragher; Edwin Sang; Beatrice Jakait; Andrew Owen; David Back; Sara Gibbons; Kay Seden; Saye H Khoo; on behalf of the USAID-Academic Model for Prevention Treatment of HIV/AIDS","Department of Pharmacology and Toxicology, Moi University School of Medicine, Eldoret, Kenya; Department of Pharmacology, Institute of Translational Medicine, The University of Liverpool, Liverpool, United Kingdom; USAID-Academic Model Providing Access to Healthcare (AMPATH), Moi University School of Medicine, Eldoret, Kenya; Liverpool School of Tropical Medicine, Liverpool, United Kingdom; NIHR Biomedical Research Centre for Microbial Diseases, Royal Liverpool University Hospital, Liverpool, United Kingdom","Conceived and designed the experiments: GK AO DB SHK. Performed the experiments: GK SG SHK KS ES BJ. Analyzed the data: GK SHK BF KS SG. Contributed reagents/materials/analysis tools: KS SG. Wrote the paper: SHK DB GK SK WN BF DB AO.","The Liverpool Drug Interactions website (DJB, SK, SG) receives sponsorship from GlaxoSmithKline, Abbott, Merck, Bristol Myers Squibb, Boehringer Ingelheim, Tibotec, Gilead, Pfizer. The website also receives funding from the UK National Institute for Health Research, the British HIV Association, The European AIDS Clinical Society and proceeds from the International Conference on Drug Therapies in HIV Infection. All other authors have declared no other competing interests from other sources with the submitted work and no financial relationships between themselves, their spouses, partners, or children relevant to the submitted work. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.","2011","02","Gabriel Kigen","GK",12,TRUE,4,6,5,7,TRUE,TRUE,FALSE,0,NA,FALSE
